
The Multabody platform’s potential clinical usefulness as a treatment for SARS-CoV-2
A multi-specific, multi-affinity antibody (Multibody, MB) platform derived from the human apoferritin protomer was used by researchers to demonstrate how combining the avidity and specificity of conventional monoclonal antibodies (MAbs) …
The Multabody platform’s potential clinical usefulness as a treatment for SARS-CoV-2 Read More